Skip to main content
SpringerLink
Log in
Book cover

Die Gynäkologie pp 467–508Cite as

Corpus uteri

  • Chapter

  • 15k Accesses

Zusammenfassung

Beim Korpuspolyp handelt sich um eine umschriebene Hyperplasie der Endometriumschleimhaut.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • ACOG (2004) ACOG Committee Opinion. Uterine artery embolizazion. Obstet Gynecol 103: 403–404c

    Google Scholar 

  • ACOG (2005) ACOG Committee on Practice Bulletins. Management of endometrial cancer. ACOG Practice Bulletin, Clinical Management Guidelines for Obstetricians – Gynecologists. Obstet Gynecol 106: 413–424

    Google Scholar 

  • AGO – Arbeitsgemeinschaft Gynäkologische Onkologie (2008) S2k- Leitlinie zur Diagnostik und Therapie des Endometriumkarzinoms (S2k-Leitlinie EndometriumKarzinom Version 2 vom .01.02.08

    Google Scholar 

  • Aoki Y, Watanabe M, Amikura T et al. (2004) Adjuvant chemotherapy as treatment of high risk stage I and II endometrial cancer. Gynecol Oncol 94: 333–339

    Article  PubMed  CAS  Google Scholar 

  • Assikis VJ, Bilimoria MM, Muenzner HD et al. (1996) Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor grade. Gynecol Oncol 63 (2): 192– 199

    Article  PubMed  CAS  Google Scholar 

  • ATAC Trialists group – Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9: 45–53

    Google Scholar 

  • Berkowitz RP, Hutchins FL, Worthington-Kirsch RL. Vaginal expulsion of submucosal fibroids after uterine artery embolization. A report of three cases. J Reprod Med 1999, 44: 373–376

    PubMed  CAS  Google Scholar 

  • Blumenfeld ML, Turner LP (1996) Role of transvaginal sonography in the evaluation of endometrial hyperplasia and cancer. Clin Obstet Gynecol 39 (3): 641–655

    Article  PubMed  CAS  Google Scholar 

  • Broder MS, Goodwin S, Chen G, Tang LJ, Costantino MM, Nguyen MH, Yegul TN, Erberich H (2003) Comparison of long-term outcomes of myomextomy and uterine artery embolization. Obstet Gynecol 2003, 100: 864

    Google Scholar 

  • Carpenter TT, Walker WJ (2005) Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG 2005, 112. 321–325

    Google Scholar 

  • Cecchini S, Ciatto S, Bonardi R et al. (1996) Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Gynecol Oncol 60 (3): 409– 411

    Article  PubMed  CAS  Google Scholar 

  • Christopherson WM, Connelly PJ, Alberhasky RC (1983) Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Cancer 51 (9): 1705– 1709

    Article  PubMed  CAS  Google Scholar 

  • Clement PB, Oliva E, Young RH (1996) Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 15 (3): 222–229

    Article  PubMed  CAS  Google Scholar 

  • Cohn DE, Horowitz NS, Mutch DG et al. (2002) Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87: 243–246

    Article  PubMed  Google Scholar 

  • Covens A, Thomas G, Shaw P et al. (1997) A phase II study of leuprolide in advanced/recurrent endometrial cancer. Gynecol Oncol 64 (1): 126–129

    Article  PubMed  CAS  Google Scholar 

  • Coronado PJ (2001) P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression. Eur J Obstet Gynecol Reprod Biol 98 (1): 103–108

    Article  PubMed  CAS  Google Scholar 

  • Cragun JM, Havrilesky LJ, Calingaert B et al. (2005) Retrospective analysis of selective lymphadenectomy in the treatment of endometrial cancer. JCO 23: 3668–3675

    Article  Google Scholar 

  • Creasman WT, Odicino FT et al. (2001) Carcinoma of the corpus uteri. J Epidemiol Biostat 6: 47–86

    PubMed  CAS  Google Scholar 

  • Creutzberg CL, van Putten WLJ, Doper PC et al. (2003) Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89: 201–209

    Article  PubMed  Google Scholar 

  • Creutzberg CL, van Putten WL, Koper PC et al. (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carci-noma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355: 1404–1411

    Article  PubMed  CAS  Google Scholar 

  • Dannecker C, Kolben M, Kürzel R (2007) Manual Malignome des Corpus uteri. München: W. Zuckschwerdt-Verlag

    Google Scholar 

  • De Blok S, de Vries C, Prinnsen HM, Bkaauwgeers HL, Jorna-Meijer L (2003) Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol 14: 779–783

    Article  PubMed  Google Scholar 

  • De Iaco PA, Muzzupapa G, Golfieri R, Ceccarini M, Roset B, Baroncini S (2002) A uterine wall defect after uterine artery embolization for symptomatic myomas. Fertil Steril: 176–176

    Google Scholar 

  • Del Maschio A, Vanzulli A, Sironi S et al. (1993) Estimating the depth of myometrial involvement by enometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. Am J Roentgenol 160 (3): 533–538

    Google Scholar 

  • De Smet F, De Brabanter J, Van den Bosch T et al. (2006) New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography. Ultrasound Obstet Gynecol 27 (6): 664–671

    Article  PubMed  Google Scholar 

  • Dietel M (2001) The histological diagnosis of endometrial hyperplasia. Is there a need to simplify? Virchows Arch 439: 604–608 Douchi T, Ijuin H, Nakamura S et al. (1997) Correlation of body fat distribution with grade of endometrial cancer. Gynecol Oncol 65 (1): 138–142

    Google Scholar 

  • Emons G, Günthert A, Hawighorst T, Hanf V (2003a) Endokrine Therapie des Endometriumkarzinoms und seiner Präkanzerosen. Onkologe 9: 1234–1240

    Article  Google Scholar 

  • Emons G, Gründker C, Hanf V (2003b) Sind Östrogene Karzigogene? Gynäkologe 36: 182–189

    Google Scholar 

  • Emons G, Beckmann MW, Böing C, Ebert A, Haensgen G et al. (2006) für die Kommission Uterus der AGO. Endometriumkarzinom. In: Kaufmann M, Beckmann MW, Emons G, Dall P et al. (Hrsg) Aktuelle Empfehlungen der Arbeitsgemeinschaft Gynäkologische Onkologie. München: W. Zuckschwerdt-Verlag, S 179–195

    Google Scholar 

  • Evans-Metcalf ER, Brooks SE, Reale FR et al. (1998) Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91: 349–354

    Article  PubMed  CAS  Google Scholar 

  • Fedele L, Bianchi S, Raffaelli R, Zanconato G (2000) A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas. Eur J Obstet Gynecol Reprod Biol 88 (1): 91–94

    Article  PubMed  CAS  Google Scholar 

  • Felemban A, Stein L, Tulandi T. Uterine restoration after repeated expulsion of myomas after uterine artery embolization. J Am Assoc Gynecol Laparosc 2001, 8: 442–444

    Article  PubMed  CAS  Google Scholar 

  • FIGO Committe on Gynaecologic Oncology (2000) Staging classifications and clinical practice and guidelines of gynaecologic cancers. Int J Gynecol Obstetr 70: 207–312

    Google Scholar 

  • Filicori M, Hall DA, Loughlin JS et al (1983) A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 147: 726–727

    PubMed  CAS  Google Scholar 

  • Fishman DA, Roberts KB, Chambers JT, Kohorn EI, Schwartz PE, Chambers SK (1996) Radiation therapy as exclusive treatment for medically patients with stage I and II endometrioid carcinoma of the endometrium. Gynecol Oncol 61: 189–196

    Article  PubMed  CAS  Google Scholar 

  • Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Tucker Burks R (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastin in advanced endometrial car-cinoma: a Gynecologic Oncology Group study. J Clin Oncol 22: 2159–2166

    Article  PubMed  CAS  Google Scholar 

  • Fowler JM (1996) Laparoscopic staging of endometrial cancer. Clin Obstet Gynecol 39 (3): 669–685

    Article  PubMed  CAS  Google Scholar 

  • Franchi M, Ghezzi F, Melpignano M et al. (2000) Clinical value of intraoperative gross examination in endometrial cancer. Gynecol Oncol 76: 357–361

    Article  PubMed  CAS  Google Scholar 

  • Gallinat A, Lueken RP (1993) Addendum-current trends in the therapy of myomata. In: Lueken RP, Gallinat A (eds) Endoscopic surgery in gynecology. Hamburg: Demeter: 69

    Google Scholar 

  • Gätje R, Kaufmann M (2009) Therapiemöglichkeiten beim Uterus myomatosus. Gynäkol Prax 33: 279–290

    Google Scholar 

  • Gätje R, Zangos S, Vogl T, Kaufmann M (2003) Myomembolisation – Pelviperitonitis bei abszediertem, nekrotischem Myom. Geburtsh Frauenheilk 2003; 63: 156–159

    Article  Google Scholar 

  • Gätje R, Mavrova-Risteska L, Zangos S, Karn T, Kissler S, Vogl T, Kaufmann M (2007) Clinical outcome after myomectomy versus uterine artery embolization for uterine fibroids. Geburtsh Frauenheilkd 67: 748–752

    Article  Google Scholar 

  • Gätje R, Kissler S, Scharl A, Ahr A, Kaufmann M (2008a) Therapiemöglichkeiten der uterinen Blutungsstörungen. Frauenarzt 47: 738– 741

    Google Scholar 

  • Gätje R, Rody A, Kaufmann M (2008b) Therapiemöglichkeiten beim Uterus myomatosus – neue Aspekte. Geburtsh Frauenheilkd 68: 487–491

    Article  Google Scholar 

  • Gebhard C (1899) Veit's Handbuch der Gynäkologie 2: 439

    Google Scholar 

  • Goodman A, Zukerberg LR, Rice LW, Fuller AF, Young RH, Scully RE (1996) Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature. Gynecol Oncol 61 (1): 54–60

    Article  PubMed  CAS  Google Scholar 

  • Goldberg J, Pereira L, Berghella V, Diamond J, Darai E, Seinera P, Seracchiolo R. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparsoscopic myomectomy. Am J Obstet Gynecol, 2004, 191: 18

    Google Scholar 

  • Goodwin SC, Spies JB (2009) Uterine fibroid embolization. N Engl J Med 361: 690–697

    Article  PubMed  CAS  Google Scholar 

  • Gretz HF rd, Economos K, Husain A et al. (1996) The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol 61 (3): 409–415

    Article  Google Scholar 

  • Hamel NW, Sebo TJ, Wilson TO et al. (1996) Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 62 (2): 192–198

    Article  PubMed  CAS  Google Scholar 

  • Hampel H et al. (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66: 7810–7817

    Article  PubMed  CAS  Google Scholar 

  • Harmanli OH, Shunmugham S, Shen T et al. (2004) The negative predictive value of , inadequate’ endometrial biopsy in diagnosing endometrial neoplasia. Obstetr Gynecol Surv 59 (8): 584–585

    Article  Google Scholar 

  • Havrilesky LJ, Cragun JM, Calingaert B, Secord AA, Valea FA, Clarke- Pearson DL, Berchuck A, Soper JT (2007) The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol 104: 401–405

    Article  PubMed  Google Scholar 

  • Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ II, Chen VW (1996) Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 88 (6): 919–926

    Article  PubMed  CAS  Google Scholar 

  • Horn–Ross PL, John EM, Canchola AJ et al. (2003) Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95: 1158– 1164

    Article  PubMed  Google Scholar 

  • Hogberg T, Rosenberg P, Kristensen G et al. (2007) A randomized phase III study on adjuvant treatment with radiation (RT) chemotherapy (CT) in early high-risk endometrial cancer (NSGO-EC- 9501/EORTC 55991). J Clin Oncol 25: 18S

    Google Scholar 

  • Huang LY, Cheng YF, Huang CC, Chang SY, Kung FT. Incomplete vaginal expulsion of pyoadenomyoma with sepsis and focal bladder necrosis after uterine artery embolization for symptomatic adenomyosis: case report. Hum Reprod 2003, 18: 167–171

    Article  PubMed  Google Scholar 

  • Huh WJ, Powell M, Leath CA III et al. (2003) Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Obstet Gynecol 91: 470–475

    Google Scholar 

  • Hutchins FL, Worthington-Kirsch R, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomativ leiomyomata uteri. J Am Assoc Gynecol Laparosc 1999, 6: 279–284

    Article  PubMed  Google Scholar 

  • Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT (1996) Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer. Gynecol Oncol 63 (1): 47–52

    Article  PubMed  CAS  Google Scholar 

  • Jongen VH (2009) Aromatase, cyclooxygenase 2, HER-2/neu, and p53 as prognostic factors in endometrioid endometrial cancer. Int J Gynecol Cancer 19 (4): 670–606

    Article  PubMed  Google Scholar 

  • Kaku T, Tsukamoto N, Hachisuga T et al. (1996) Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 60 (1): 22–25

    Article  PubMed  CAS  Google Scholar 

  • Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ (1997) Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 79 (2): 320–327

    Article  PubMed  CAS  Google Scholar 

  • Knocke TH, Kucera H, Weidinger B et al. (1997) Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 37 (2): 359–365

    Article  PubMed  CAS  Google Scholar 

  • Kohler MF, Carney P, Dodge R et al. (1996) p53 overexpression in advanced- stage endometrial adenocarcinoma. Am J Obstet Gynecol 175 (5): 1246–1252

    Article  PubMed  CAS  Google Scholar 

  • Kong A, Simera I, Collingwood M, Williams C, Kitchener H (2007) Adjuvant radiotherapie for stage I endometrial cancer: systematic review and meta- analysis. Ann Oncol 18: 1596–1604

    Article  Google Scholar 

  • Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT (1996) High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 14 (2): 357– 361

    PubMed  CAS  Google Scholar 

  • Lethaby A, Vollenhoven B, Sowter M (2002) Efficacy of pre-operative gonadotropin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. Br J Obstet Gynaecol 109: 1097–108

    Article  CAS  Google Scholar 

  • Li TC, Mortimer R, Cooke ID (1999) Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 14 (7): 1735–1740

    Article  PubMed  CAS  Google Scholar 

  • Lukka H, Chambers A, Fyles A, Thephamongkhol K, Fung-Kee-Fung M, Elit L, Kwon J (2006) Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review. Gynecol Oncol 102: 361–368

    Article  PubMed  Google Scholar 

  • Marsden DE, Hacker NF (2001) Optimal management of endometrial hyperplasia. Best Pract Res Clin Obstet Gynaecol 15: 393–405

    Article  PubMed  CAS  Google Scholar 

  • Mall A, Shirk G, Van Voorhis BJ (2002) Previous tubal ligation is a risk factor for hysterectomy after rollerball endometrial ablation. Obstet Gynecol 100: 659–664

    Article  PubMed  Google Scholar 

  • Marret H, Alonso AM, Cottier JP, Tranquart F, Herbreteau D, Body G (2003) Leiomyoma recurrence after uterine artery embolization. J Vasc Interv Radiol 14 (11): 1395–1399

    Article  PubMed  Google Scholar 

  • Meyer WR. Embolization of uterine fibroids. RSNA 2001, Chicago

    Google Scholar 

  • Montgomery BE, Daum GS, Dunton CJ (2004) Endometrial hyperplasia: a review. Obstetr Gynecol Surv 59 (5): 368–378

    Article  Google Scholar 

  • Morris M, Alvarez RD, Kinney WK, Wilson TO (1996) Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol 60 (2): 288–291

    Article  PubMed  CAS  Google Scholar 

  • Nag S (1996) Modern techniques of radiation therapy for endometrial cancer. Clin Obstet Gynecol 39 (3): 728–744

    Article  PubMed  CAS  Google Scholar 

  • National Comprehensive Cancer Centre Network – NCCN (2006) Uterine cancers. The complete library of NCCN Clinical Practice Guidelines in Oncology. [www.nccn.org]

  • Neven P (2000) Guidelines for monitoring patients taking tamoxifen treatment. Drug Safety 22 (1):1–11

    Article  PubMed  CAS  Google Scholar 

  • Nicklin JL, Copeland LJ (1996) Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin Obstet Gynecol 39 (3): 686–695

    Article  PubMed  CAS  Google Scholar 

  • Obel JC, Friberg G, Fleming GF (2006) Chemotherapy in endometrial cancer. Clin Adv Hematol Oncol 4: 459–468

    PubMed  Google Scholar 

  • Odicino F (2007) FIGO Report on the results of treament in gynecologic cancer 2007. Gynecol Oncol 107, 1 Suppl 1: 8–9

    Article  Google Scholar 

  • Partridge EE, Shingleton HM, Menck HR (1996) The National Cancer Data Base report on endometrial cancer. J Surg Oncol 61: 111– 123

    Article  PubMed  CAS  Google Scholar 

  • Payne JF, Haney AF. Serious complications of uterine artery embolization for conservative treatment of fibroids. Fertil Steril 2003, 79: 128–131

    Article  PubMed  Google Scholar 

  • Plaxe SC, Saltzstein SL, Elliott EA, Matanoski GM, Rosenshein NB, Grumbine FC, Diamond EL (1997) Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol 65 (1): 8–12

    Article  PubMed  CAS  Google Scholar 

  • Pollard RR. Goldberg JM. Prolapsed cervical myoma after uterine artera embolization. A case report. J Reprod Med 2001, 46: 499– 500

    PubMed  CAS  Google Scholar 

  • Preyer O, Obermair A, Formann E et al. (2002) The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol 86: 269–273

    Article  PubMed  Google Scholar 

  • Pron G, Mocarski E, Bennett J, Vilos G, Common G, Vanderburgh L. Pregnancy after uterine artery embolisation for leiomyomata: the Ontaria multicenter trial. Obstet Gynecol 2005, 105. 67–76

    Article  PubMed  Google Scholar 

  • Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA (2006) Randomized phase III trial of whole-abdominal irradiation ver-sus doxorubicin and cisplatin chemotherapy in advanced endometrial carci-noma: A Gynecologic Oncology Group study. J Clin Oncol 24: 36–44

    Article  PubMed  CAS  Google Scholar 

  • Ravazi MK, Hwang G, Jahed A, Modanloo S, Chen B. Abdominal myomectomy versus uterine fibroid embolization in the treatment of symptomatic leiolyomas. Am J Roetgenol 2003, 180: 1571–1575

    Google Scholar 

  • Revel A, Tsafrir A, Anteby SO, Shushan A (2004) Does hysteroscopy produce intraperitoneal spread of endometrial cancer cells? Obstetr Gynecol Surv 59 (4): 280–284

    Article  Google Scholar 

  • Sauer G et al. (2007) Diagnostische Verfahren beim Endometriumkarzinom. Gynäkologe 1 (40):14–19

    Article  Google Scholar 

  • Schmeler K. Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome. NEJM 2006 354:261–269

    Article  PubMed  CAS  Google Scholar 

  • Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF (1996) The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 63: 34–39

    Article  PubMed  CAS  Google Scholar 

  • Shashoua AR, Stringer NH, Pearlman JB, Behrmaram B, Stringer E. Ischemic uterine rupture and hysterectomy 3 months after uterine artery embolization. J Am Assoc Gynecol Laparosc 2002, 9: 217–220

    Article  PubMed  Google Scholar 

  • Shumsky AG, Brasher PM, Stuart GC et al. (1997) Risk-specific followup for endometrial carcinoma patients. Gynecol Oncol 65 (3): 379–382

    Article  PubMed  CAS  Google Scholar 

  • Siskin GP, Stainken BF, Dowling K, Meo PRN, Ahn J, Dolen EG. Outpatients uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. JVIR 2000, 11: 305–311

    Article  PubMed  CAS  Google Scholar 

  • Spies JB, Ascher SA, Roth AR, Kim J, Levy E, Gomez-Jorge J (2001) Uterine Artery Embolization for Leiomyomata. Obstet Gyn 2001, 98: 29–34

    Article  Google Scholar 

  • Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM (2001) Ovarian function after uterine artery embolization for leiomyomata: assessment with use of follicle stimulating hormone assay. JVIR 12: 437–442

    Article  PubMed  CAS  Google Scholar 

  • Sultana CJ, Goldberg J, Aizenman L, Chon JK. Vesicouterine fistula after uterine artery embolization: a case report. Am J Obstet Gynecol 2002, 187: 1726–1727

    Article  PubMed  Google Scholar 

  • Sutton GP, Blessing JA, DeMars RL, Moore D, Burke TW, Grendys EC (1996) A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol 63 (1): 25–27

    Article  PubMed  CAS  Google Scholar 

  • Taylor HB, Norris HJ (1966) Mesenchymal tumors of the uterus: IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 82: 40

    PubMed  CAS  Google Scholar 

  • Tepper R, Beyth Y, Altaras MM, Zalel Y, Shapira J, Cordoba M, Cohen I (1997) Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 64 (3): 386– 391

    Article  PubMed  CAS  Google Scholar 

  • Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12: 130–136

    Article  PubMed  Google Scholar 

  • Van Wijk FH, Huikeshoven FJ, Abdulkadir L, Ewing PC, Burger CW (2006) Stage III and IV endometrial cancer: a 20-year review of patients. Int J Gynecol Cancer 16: 1648–1655

    Article  PubMed  Google Scholar 

  • Zaino RJ (2000) Endometrial hyperplasia: Is it time for a quantum leap to a new classification? Internat J Gynecol Pathol 19: 314–321

    Article  CAS  Google Scholar 

  • Zreik TG, Rutherford TJ, Palter SF, Troiano RN, Williams E, Brown JM, Olive DL (1998) Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids. J Am Assoc Gynecol Laparosc 5 (1): 33–38

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ehem. Universitätsfrauenklinik Ulm, Prittwitzstraße 43, 89075, Ulm

    Prof. Dr. med. R. Kreienberg

  2. Universitätsfrauenklinik Ulm, Prittwitzstraße 43, 89075, Ulm

    Dr. med. Z. Atassi

  3. Klinikum Fürth, Jakob-Henle-Straße 1, 90766, Furth

    Prof. Dr. med. V. Hanf

Authors
  1. Prof. Dr. med. R. Kreienberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. Z. Atassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. V. Hanf
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Johann-Wolfgang-Goethe-Universität Frankfurt, Universitätsfrauenklinik, Frankfurt

    Manfred Kaufmann

  2. Otto-von-Guericke-Universität Magdeburg, Universitätsfrauenklinik, Magdeburg

    Serban D. Costa

  3. Friedrich-Alexander-Universität Erlangen-Nürnberg, Klinikum St. Marien, Lehrkrankenhaus der Universität Regensburg, Erlangen-Nürnberg

    Anton Scharl

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kreienberg, R., Atassi, Z., Hanf, V. (2013). Corpus uteri. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-20923-9_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-20922-2

  • Online ISBN: 978-3-642-20923-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation